Related references
Note: Only part of the references are listed.Optimization of Class I Histone Deacetylase PROTACs Reveals thatHDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells
Joshua P. Smalley et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
Salma Darwish et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8
Zhiqiang Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease Pathology
Natsuko Macabuag et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Development of the first non-hydroxamate selective HDAC6 degraders
Tim Keuler et al.
CHEMICAL COMMUNICATIONS (2022)
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Jiranan Chotitumnavee et al.
CHEMICAL COMMUNICATIONS (2022)
Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands
Yingxin Lu et al.
MOLECULES (2021)
Targeted protein degraders crowd into the clinic
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP
Mengzhu Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
TF-PROTACs Enable Targeted Degradation of Transcription Factors
Jing Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Chemo-proteomics exploration of HDAC degradability by small molecule degraders
Yuan Xiong et al.
CELL CHEMICAL BIOLOGY (2021)
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida et al.
SLAS DISCOVERY (2021)
A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Role of HDACs in normal and malignant hematopoiesis
Pan Wang et al.
MOLECULAR CANCER (2020)
Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel-Lindau (VHL) E3 Ubiquitin Ligase
Ka Yang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
A Simple and Scalable Strategy for Analysis of Endogenous Protein Dynamics
Marie K. Schwinn et al.
SCIENTIFIC REPORTS (2020)
Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual-Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
Laura Sinatra et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups
Nina Ressing et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)
Fangyuan Cao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs
Yufeng Xiao et al.
CHEMICAL COMMUNICATIONS (2020)
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Dhanusha A. Nalawansha et al.
CELL CHEMICAL BIOLOGY (2020)
A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders
Ka Yang et al.
CELL CHEMICAL BIOLOGY (2020)
PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes
Joshua P. Smalley et al.
CHEMICAL COMMUNICATIONS (2020)
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
Yves Depetter et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
Hao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Fluorinated Analogues of the Histone Deacetylase Inhibitor Vorinostat (Zolinza): Validation of a Chiral Hybrid Bioisostere, BITE
Nathalie Erdeljac et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6
Jeremy D. Osko et al.
BIOCHEMISTRY (2019)
Single-pot, solid-phase-enhanced sample preparation for proteomics experiments
Christopher S. Hughes et al.
NATURE PROTOCOLS (2019)
Developing potent PROTACs tools for selective degradation of HDAC6 protein
Zixuan An et al.
PROTEIN & CELL (2019)
PROTAC-mediated crosstalk between E3 ligases
Christian Steinebach et al.
CHEMICAL COMMUNICATIONS (2019)
Plasticity in designing PROTACs for selective and potent degradation of HDAC6
Haiyan Yang et al.
CHEMICAL COMMUNICATIONS (2019)
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
Matthias Schiedel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
Ka Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Targeted protein degradation by PROTACs
Taavi K. Neklesa et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach
Kai-Cheng Hsu et al.
SCIENTIFIC REPORTS (2017)
Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease
Sida Shen et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Practical synthesis of a phthalimide-based Cereblon ligand to enable PROTAC development
Jasmin Lohbeck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Histone deacetylase inhibitors as cancer therapeutics
Gary A. Clawson
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer
Chih-Jen Yang et al.
ONCOTARGET (2015)
High-Fat Diet Induced Isoform Changes of the Parkinson's Disease Protein DJ-1
Gereon Poschmann et al.
JOURNAL OF PROTEOME RESEARCH (2014)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
C3 Halogen and C8 Substituents on Stilbene Arotinoids Modulate Retinoic Acid Receptor Subtype Function
Susana Alvarez et al.
CHEMMEDCHEM (2009)
Copper-catalyzed synthesis of benzimidazoles via cascade reactions of o-haloacetanilide derivatives with amidine hydrochlorides
Daoshan Yang et al.
JOURNAL OF ORGANIC CHEMISTRY (2008)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
Share Paper
